Literature DB >> 1664040

Identification of an endothelial cell surface protein that binds plasminogen.

A K Dudani1, S Hashemi, M T Aye, P R Ganz.   

Abstract

To identify and characterize endothelial cell surface components that bind plasminogen, we used ligand-blotting to study binding of plasminogen to sodium dodecyl sulphate solubilized extracts of human umbilical vein endothelial cells. It was observed that glu-plasminogen bound predominantly to a 45 kDa endothelial cell polypeptide. The interaction of labelled glu-plasminogen with this polypeptide was reversible and specific as the binding could be inhibited by both excess cold lysine and unlabelled glu-plasminogen but not by unrelated proteins. Binding of glu-plasminogen to cell extracts prepared from endothelial cells that had been pretreated with proteinase K was significantly reduced indicating that the 45 kDa polypeptide is a cell-surface protein. The cell-surface localization of the 45 kDa polypeptide was also indicated by the positive interaction of glu-plasminogen with membrane fractions of endothelial cells. Lys-plasminogen also interacted with the 45 kDa polypeptide in a specific manner and reversibility experiments indicated that lys-plasminogen could also displace the bound glu-plasminogen. Since binding of plasminogen to the 45 kDa endothelial cell surface polypeptide was very similar to plasminogen binding to intact endothelial cells, we propose that the 45 kDa protein represents one of the major receptors for plasminogen on human endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1664040     DOI: 10.1007/bf00233117

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  16 in total

1.  Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells.

Authors:  L A Miles; E F Plow
Journal:  Thromb Haemost       Date:  1987-10-28       Impact factor: 5.249

2.  Plasminogen interacts with human platelets through two distinct mechanisms.

Authors:  L A Miles; M H Ginsberg; J G White; E F Plow
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

5.  Binding and activation of plasminogen on the platelet surface.

Authors:  L A Miles; E F Plow
Journal:  J Biol Chem       Date:  1985-04-10       Impact factor: 5.157

6.  Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface.

Authors:  K A Hajjar; R L Nachman
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

7.  Human factor VIII from heparinized plasma. Purification and characterization of a single-chain form.

Authors:  P R Ganz; E S Tackaberry; D S Palmer; G Rock
Journal:  Eur J Biochem       Date:  1988-01-04

8.  Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells.

Authors:  L A Miles; C M Dahlberg; E G Levin; E F Plow
Journal:  Biochemistry       Date:  1989-11-28       Impact factor: 3.162

9.  Binding of plasminogen to cultured human endothelial cells.

Authors:  K A Hajjar; P C Harpel; E A Jaffe; R L Nachman
Journal:  J Biol Chem       Date:  1986-09-05       Impact factor: 5.157

10.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

View more
  1 in total

1.  Plasminogen and angiostatin interact with heat shock proteins.

Authors:  Anil K Dudani; Jelica Mehic; Anthony Martyres
Journal:  Mol Cell Biochem       Date:  2007-01-06       Impact factor: 3.842

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.